Ketoacidosis in Children and Adolescents With Newly Diagnosed Type 1 Diabetes During the COVID-19 Pandemic in Germany

Clemens Kamrath; Kirsten Mönkemöller; Torben Biester; Tilman R Rohrer; Katharina Warncke; Johanna Hammersen; Reinhard W Holl

doi:10.1001/jama.2020.13445

Ketoacidosis in Children and Adolescents With Newly Diagnosed Type 1 Diabetes During the COVID-19 Pandemic in Germany

JAMA. 2020 Aug 25;324(8):801-804. doi: 10.1001/jama.2020.13445.

Authors

Clemens Kamrath¹, Kirsten Mönkemöller², Torben Biester³, Tilman R Rohrer⁴, Katharina Warncke⁵, Johanna Hammersen⁶, Reinhard W Holl⁷

Affiliations

¹ Center of Child and Adolescent Medicine, Justus Liebig University, Giessen, Germany.
² Department of Pediatrics, Kinderkrankenhaus Amsterdamer Strasse, Cologne, Germany.
³ Diabetes Center for Children and Adolescents, Children's Hospital Auf der Bult, Hannover, Germany.
⁴ Department of Pediatrics, Saarland University Medical Center, Homburg/Saar, Germany.
⁵ Department of Pediatrics, Technical University of Munich School of Medicine, Munich, Germany.
⁶ Department of Pediatrics, University Hospital Erlangen, Erlangen, Germany.
⁷ Institute of Epidemiology and Medical Biometry (ZIBMT), Ulm University, Ulm, Germany.

Abstract

This study uses diabetes registry data to compare the frequency of diabetic ketoacidosis (DKA) in children and adolescents at time of type 1 diabetes diagnosis in Germany during the first 2 months of the coronavirus disease 2019 (COVID-19) pandemic vs the same time period in 2018 and 2019.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
COVID-19
Child
Child, Preschool
Coronavirus Infections*
Diabetes Mellitus, Type 1 / complications*
Diabetes Mellitus, Type 1 / diagnosis
Diabetic Ketoacidosis / epidemiology*
Diabetic Ketoacidosis / etiology
Germany / epidemiology
Humans
Pandemics*
Patient Acceptance of Health Care
Pneumonia, Viral*